Newsletter | October 22, 2024

10.22.24 -- What's In The Leukopak Matters For Cell Therapy Manufacturing

SPONSOR

Does Choosing a Large CRO Truly Reduce Risk?

In our outsourcing industry, it is never an easy decision to select a partner when trying to run complex sequential trials. The need to gain regulatory approval for the treatments you have dedicated yourself to providing, coupled with the need to find a capable, reliable, and fair Contract Research Organization is quite daunting. Discover how a smaller CRO may be better suited to see your study through.

FEATURED EDITORIAL

What's In The Leukopak Matters For Cell Therapy Manufacturing

Advanced cell-based therapies are impossible without high-quality leukopaks from high-quality donors.

INDUSTRY INSIGHTS

Revolutionizing Trial Supply Management With The Power of Free Picking

Discover the power of SmartSignals RTSM’s new free picking feature, designed to revolutionize trial supply management by optimizing efficiency and reducing costs.

Specialized Expertise For Efficient Management Of Clinical Supply Budgets

A financial project analyst (FPA) plays a critical role in clinical trial supply and budget management. Explore how sponsors can benefit from having this specialist on their supply partner's team.

Selecting Container Closure Systems With Confidence: Lyophilization

Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.

SOLUTIONS

Perceptive eClinical: Clinical Trial Solutions